Core Scientific, Inc.
CORZQ · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $502 | $640 | $544 | $60 |
| % Growth | -21.5% | 17.6% | 802.7% | – |
| Cost of Goods Sold | $379 | $632 | $306 | $51 |
| Gross Profit | $123 | $8 | $239 | $9 |
| % Margin | 24.6% | 1.3% | 43.9% | 15.6% |
| R&D Expenses | $7 | $27 | $8 | $5 |
| G&A Expenses | $94 | $213 | $61 | $15 |
| SG&A Expenses | $101 | $226 | $65 | $16 |
| Sales & Mktg Exp. | $7 | $13 | $4 | $2 |
| Other Operating Expenses | $0 | $0 | $0 | -$0 |
| Operating Expenses | $108 | $253 | $72 | $22 |
| Operating Income | $9 | -$2,110 | $131 | -$6 |
| % Margin | 1.8% | -329.5% | 24.2% | -10.5% |
| Other Income/Exp. Net | -$261 | -$1,919 | -$104 | -$6 |
| Pre-Tax Income | -$246 | -$2,163 | $63 | -$12 |
| Tax Expense | $1 | -$17 | $16 | $0 |
| Net Income | -$246 | -$2,146 | $47 | -$12 |
| % Margin | -49.1% | -335.2% | 8.7% | -20.2% |
| EPS | -0.644 | -6.3 | 0.15 | -0.039 |
| % Growth | 89.8% | -4,300% | 489.6% | – |
| EPS Diluted | -0.644 | -6.3 | 0.15 | -0.039 |
| Weighted Avg Shares Out | 382 | 341 | 317 | 317 |
| Weighted Avg Shares Out Dil | 382 | 341 | 317 | 317 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $86 | $97 | $44 | $4 |
| Depreciation & Amortization | $96 | $226 | $33 | $9 |
| EBITDA | $114 | -$211 | $184 | $12 |
| % Margin | 22.8% | -32.9% | 33.8% | 19.8% |